Sarepta Therapeutics
SRPT
#1513
Rank
$11.36 B
Marketcap
$118.97
Share price
-0.42%
Change (1 day)
31.10%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total assets

Total assets on the balance sheet as of September 2024 : $3.59 Billion USD

According to Sarepta Therapeutics 's latest financial reports the company's total assets are $3.59 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$3.26 B4.35%
2022-12-31$3.12 B-0.62%
2021-12-31$3.14 B5.47%
2020-12-31$2.98 B63.74%
2019-12-31$1.82 B11.01%
2018-12-31$1.64 B25.54%
2017-12-31$1.30 B208.41%
2016-12-31$0.42 B54.91%
2015-12-31$0.27 B-7.2%
2014-12-31$0.29 B1.19%
2013-12-31$0.29 B42.23%
2012-12-31$0.20 B277.05%
2011-12-31$54.36 M18.25%
2010-12-31$45.97 M-23.41%
2009-12-31$60.02 M135.07%
2008-12-31$25.53 M-33.91%
2007-12-31$38.63 M-5.44%
2006-12-31$40.86 M-27.56%
2005-12-31$56.4 M97.79%
2004-12-31$28.51 M-39.51%
2003-12-31$47.14 M64.82%
2002-12-31$28.6 M-15.41%
2001-12-31$33.81 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$54.52 B 1,414.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.71 B-52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.64 B-54.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.49 B-86.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.20 B 16.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.84 B-48.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.05 B-42.97%๐Ÿ‡บ๐Ÿ‡ธ USA